Jonat W, Maass H
Arch Geschwulstforsch. 1981;51(7):637-41.
The determination of hormone receptors in tumor tissue samples today is accepted as a necessary step with in a selective treatment plan for patients with breast cancer. The following way discussed our clinical knowledge about hormone receptors in breast cancer. Besides a therapy concept for metastatic breast cancer an adjuvant treatment trial for stage II breast cancer patients based on the estrogen receptor status will be presented.
如今,在乳腺癌患者的选择性治疗方案中,测定肿瘤组织样本中的激素受体已被视为必要步骤。以下将阐述我们关于乳腺癌激素受体的临床知识。除了转移性乳腺癌的治疗理念外,还将介绍一项基于雌激素受体状态的II期乳腺癌患者辅助治疗试验。